Hospira Sues FDA Over Generic Precedex Carve-Out Approval

Hospira Sues FDA Over Generic Precedex Carve-Out Approval

Hospira Inc. hit the U.S. Food and Drug Administration with a suit on Monday contesting the agency’s approval of generic versions of its blockbuster sedative Precedex, claiming the FDA violated its own rules in allowing generics for uses still protected ...read more

  • Tags: